Table 3 Frequency of each KIR gene in patients (N = 39) and controls (N = 136)
From: KIR repertory in patients with hematopoietic diseases and healthy family members
KIR gene | Patient | Control | p-value | |
|---|---|---|---|---|
(n = 39) | (n = 136) | |||
Framework | KIR2DL4 | 39 (100 %) | 136 (100 %) | 1.0000 |
KIR3DL2 | 39 (100 %) | 136 (100 %) | 1.0000 | |
KIR3DL3 | 39 (100 %) | 136 (100 %) | 1.0000 | |
KIR3DP1 | 39 (100 %) | 136 (100 %) | 1.0000 | |
Haplotype A | KIR2DS4 | 36 (92 %) | 129 (95 %) | 0.6936 |
KIR2DL1 | 35 (90 %) | 130 (96 %) | 0.2329 | |
KIR2DL3 | 36 (92 %) | 118 (87 %) | 0.4173 | |
KIR3DL1 | 37 (95 %) | 129 (95 %) | 1.0000 | |
Haplotype B | KIR2DS1 | 6 (15 %) | 59 (43 %) | 0.0013 ( a ) |
KIR2DS2 | 12 (31 %) | 78 (57 %) | 0.0038 ( a ) | |
KIR2DS3 | 5 (13 %) | 45 (33 %) | 0.0153 ( a ) | |
KIR2DS5 | 11 (28 %) | 45 (33 %) | 0.6976 | |
KIR3DS1 | 10 (26 %) | 53 (39 %) | 0.1356 | |
KIR2DL2 | 9 (23 %) | 75 (55 %) | 0.0005 ( a ) | |
KIR2DL5 | 11 (28 %) | 72 (53 %) | 0.0067 ( a ) | |
Haplotype A/B | KIR2DP1 | 37 (95 %) | 131 (96 %) | 0.6465 |